• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

GAO Push for Lower Dialysis Bundle Spurs Controversy

Article

Dialysis and kidney-care providers are taking issue with a Government Accountability Office report released this month that found the government may be over-paying for end-stage renal disease treatment.

The report called on the CMS to re-examine the amount it's paying (PDF) for dialysis care, arguing that the agency bases its bundled payment rates on 5-year-old drug utilization trends that are no longer current.

It added that if the payments accurately reflected current prescribing trends for end-stage renal disease, Medicare would have saved at least $650 million in 2011, up to as much as $880 million—and that those savings are only forecasted to grow.

Read the full story: http://bit.ly/12xSDjv

Source: ModernHealthcare.com

Related Videos
Gordon Crofoot, MD, PA
Hamlet Gasoyan, PhD
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
David Awad, PharmD, BCOP
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Ali Khawar
Ali Khawar
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.